Is Unicycive Therapeutics Inc (UNCY) Stock at the Top of the Biotechnology Industry?

The 60 rating InvestorsObserver gives to Unicycive Therapeutics Inc (UNCY) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 77 percent of stocks in the Biotechnology industry, UNCY’s 60 overall rating means the stock scores better than 60 percent of all stocks.

UNCY has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on UNCY!

See Full UNCY Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Unicycive Therapeutics Inc Stock Today?

Unicycive Therapeutics Inc (UNCY) stock is unchanged -0.57% while the S&P 500 is down -0.23% as of 3:40 PM on Friday, Dec 29. UNCY is unchanged $0.00 from the previous closing price of $0.87 on volume of 561,896 shares. Over the past year the S&P 500 is higher by 23.98% while UNCY is up 55.36%. UNCY lost -$1.75 per share the over the last 12 months. Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock.